Llwytho...

Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types

Overexpression of the chondroitin sulfate proteoglycan 4 (CSPG4) has been associated with the pathology of multiple types of such as melanoma, breast cancer, squamous cell carcinoma, mesothelioma, neuroblastoma, adult and pediatric sarcomas, and some hematological cancers. CSPG4 has been reported to...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Immunol
Prif Awduron: Ilieva, Kristina M., Cheung, Anthony, Mele, Silvia, Chiaruttini, Giulia, Crescioli, Silvia, Griffin, Merope, Nakamura, Mano, Spicer, James F., Tsoka, Sophia, Lacy, Katie E., Tutt, Andrew N. J., Karagiannis, Sophia N.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2018
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5767725/
https://ncbi.nlm.nih.gov/pubmed/29375561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.01911
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!